Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$772.14 - $960.02 $231,642 - $288,006
300 New
300 $265,000
Q2 2023

Jul 25, 2023

SELL
$350.74 - $468.98 $1.93 Million - $2.58 Million
-5,500 Reduced 50.0%
5,500 $2.58 Million
Q1 2023

Apr 14, 2023

BUY
$310.63 - $364.82 $1.71 Million - $2.01 Million
5,500 Added 100.0%
11,000 $3.78 Million
Q4 2022

Feb 08, 2023

BUY
$321.55 - $374.67 $1.77 Million - $2.06 Million
5,500 New
5,500 $2.01 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.